December 17
QLT and Novartis Provide Update on Phase II Visudyne® Studies
PDF version
November 21
QLT Streamlines Workforce and Refocuses on Key Development Activities to Ensure Continued Profitability and Growth
October 22
QLT Announces Q3 Results for 2002 and Reiterates Guidance
October 21
Long-Term Benefit of Visudyne� Therapy for Wet Age-Related Macular Degeneration Published in Archives of Ophthalmology
October 17
QLT Announces Visudyne� Sales for Third Quarter of 2002
October 11
QLT and Novartis Ophthalmics Launch Phase III Program to Treat Skin Cancer
October 3
QLT Receives FDA Fast Track Status for Tariquidar
September 24
QLT Announces Favorable Court Decision in Massachusetts Eye and Ear Infirmary (MEEI) Litigation
August 28
Visudyne� Approved for Occult Subfoveal Choroidal Neovascularisation (CNV) Secondary to Age-Related Macular Degeneration (AMD)
August 27
QLT and Novartis Ophthalmics Reach Key Milestone in their Comprehensive Clinical Trial Program for Visudyne�
July 25
QLT Announces Q2 Results for 2002 and Reiterates Guidance
July 22
QLT Announces Visudyne� Sales for Second Quarter of 2002
June 28
QLT Begins Pivotal Phase III Clinical Programs for Multi-Drug Resistance in Non-Small Cell Lung Cancer Patients
May 31
QLT and Novartis Ophthalmics Announce Positive Recommendations for Visudyne� Approval in Europe From European Committee for Proprietary Medicinal Products
May 28
Bill Newell Named Senior VP and Chief Business Officer of QLT
May 21
Tariquidar, QLT's Late Stage Cancer Compound, Shows Advantages Over Previous Generations of P-GP Inhibitors
April 23
QLT Announces Q1 Results for 2002 and Updates Guidance
Novartis Ophthalmics and QLT Announce New Drug Application for Visudyne� in Japan
Early Detection is Key to Maximizing Vision Outcomes in Age-Related Macular Degeneration
April 16
QLT Announces Visudyne� Sales for First Quarter of 2002
April 11
QLT Reduces Stock Option Request to Shareholders
April 1
QLT Updates Status of Visudyne� Therapy Reimbursement in U.S.
March 11
QLT Renews Shareholder Rights Plan
February 6
QLT Announces Year-End Results for 2001 and Provides Guidance for 2002
